Document is current
Any future updates will be listed below
-
Authors
Ferber, Dyke
El Nahhas, Omar S. M.
Wölflein, Georg
Wiest, Isabella C.
Clusmann, Jan
Leßmann, Marie-Elisabeth
Foersch, Sebastian
Lammert, Jacqueline
Tschochohei, Maximilian
Jäger, Dirk https://orcid.org/0000-0002-1276-7802
Salto-Tellez, Manuel
Schultz, Nikolaus https://orcid.org/0000-0002-0131-4904
Truhn, Daniel https://orcid.org/0000-0002-9605-0728
Kather, Jakob Nikolas https://orcid.org/0000-0002-3730-5348
- License Information
-
More Information
Article History
Received: 13 August 2024
Accepted: 29 April 2025
First Online: 6 June 2025
Competing interests
: O.S.M.E.N. holds shares in StratifAI. J.N.K. declares consulting services for Owkin, DoMore Diagnostics, Panakeia and Scailyte, holds shares in Kather Consulting, StratifAI and Synagen and has received honoraria for lectures and advisory board participation from AstraZeneca, Bayer, Eisai, MSD, BMS, Roche, Pfizer and Fresenius. D.T. has received honoraria for lectures by Bayer and holds shares in StratifAI and holds shares in Synagen. D.F. holds shares in Synagen. M.S.T. is a scientific advisor to Mindpeak and Sonrai Analytics and has received honoraria from BMS, MSD, Roche, Sanofi and Incyte. S.F. has received honoraria from MSD and BMS. The remaining authors declare no competing interests.
